2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.
David A Sandham, Clive Aldcroft, Urs Baettig, Lucy Barker, David Beer, Gurdip Bhalay, Zarin Brown, Gerald Dubois, David Budd, Louise Bidlake, Emma Campbell, Brian Cox, Brian Everatt, David Harrison, Catherine J Leblanc, Jodie Manini, Rachael Profit, Rowan Stringer, Katy S Thompson, Katharine L Turner, Morris F Tweed, Christoph Walker, Simon J Watson, Steven Whitebread, Jennifer Willis, Gareth Williams, Caroline Wilson
Global Discovery Chemistry, Novartis Institutes of Biomedical Research, Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex RH12 5AB, UK. david.sandham@novartis.com
Bioorganic & medicinal chemistry letters 2007 Aug 1High throughput screening identified a phenoxyacetic acid scaffold as a novel CRTh2 receptor antagonist chemotype, which could be optimised to furnish a compound with functional potency for inhibition of human eosinophil shape change and oral bioavailability in the rat.
Citation
David A Sandham, Clive Aldcroft, Urs Baettig, Lucy Barker, David Beer, Gurdip Bhalay, Zarin Brown, Gerald Dubois, David Budd, Louise Bidlake, Emma Campbell, Brian Cox, Brian Everatt, David Harrison, Catherine J Leblanc, Jodie Manini, Rachael Profit, Rowan Stringer, Katy S Thompson, Katharine L Turner, Morris F Tweed, Christoph Walker, Simon J Watson, Steven Whitebread, Jennifer Willis, Gareth Williams, Caroline Wilson. 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists. Bioorganic & medicinal chemistry letters. 2007 Aug 1;17(15):4347-50
Mesh Tags
Substances
PMID: 17531480
View Full Text
